comparemela.com

Latest Breaking News On - Salarius pharmaceuticals - Page 24 : comparemela.com

Salarius Pharmaceuticals Announces Acceptance of Three Abstracts for Poster Presentations at the 2021 American Society of Clinical Oncology Annual Meeting

Message : Required fields HOUSTON, April 19, 2021 (GLOBE NEWSWIRE) Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, announced today that all three submitted abstracts detailing research involving seclidemstat were accepted for poster presentations, with one abstract also selected for a poster discussion session, at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. ASCO will be held virtually from June 4-8, 2021. “We are very pleased to report that research involving seclidemstat will be the subject of three poster presentations at the 2021 ASCO Annual Meeting,” stated David Arthur, President and CEO of Salarius Pharmaceuticals. “As previously noted, the full findings from the dose escalation-stage of the Phase 1/2 trial of seclidemstat in patients with relapsed and refractory Ewing sarcoma, including details

Today s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning

Today s Market / Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday Morning Kick off the trading day on Tuesday by staying up-to-date By Sarah Smith, InvestorPlace Web Content Producer Apr 13, 2021, 7:55 am EDT April 13, 2021 Dow Jones Industrial Average off 0.34%. The S&P 500 and the Nasdaq Composite are both down too, off 0.26% and 0.05%. So what do you need to know about the pre-market stock movers? Source: ventdusud / Shutterstock.com We’ll get into the winners of the pre-market stock movers this morning below. However, before that investors should catch up on the biggest stock market news from Monday.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.